Researchers in New York City have developed a carrier in their lab that is five times more efficient in delivering DNA into cells than today’s commercial delivery methods: reagent vectors. This novel complex is a peptide-polymer hybrid, assembled from two separate, less effective vectors that are used to carry DNA into cells.
Researchers in China, working on the optimization of a third-generation sequencing technique based on nanopores, have found that long-chain DNA with low salt concentration is more conducive to the nanopore sequencing process. This finding may improve the efficiency of sequencing, and further low the cost of gene sequencing.
A new innovation may help us deal with post-Thanksgiving guilt: Biotechnologists have constructed a genetic regulatory circuit from human components that monitors blood-fat levels. In response to excessive levels, it produces a messenger substance that signals satiety to the body. Tests on obese mice reveal that this helps them to lose weight.
Viruses can not only cause illnesses in humans, they also infect bacteria. Bacteria protect themselves with a kind of immune system that detects and “chops up” foreign DNA. Scientists have now shown that the dual-RNA guided enzyme Cas9 which is involved in the process has developed independently in various strains of bacteria. This enhances the potential of exploiting the bacterial immune system for genome engineering.
Purdue Univ. researchers have successfully eliminated the native infection preferences of a Sindbis virus engineered to target and kill cancer cells, a milestone in the manipulation of this promising viral vector. The achievement also demonstrates the ability to use methods of manipulation previously only applied to proteins.
For the first time, scientists have used new technology which analyzes the whole genome to find the cause of a genetic disease in what was previously referred to as “junk DNA”. This genomic “dark matter” does not contain genes and accounts for 99% of the human genome. Instead, it is responsible for making sure that genes are “switched on” at the right time and in the right part of the body.
Scientists collaborating on an international research project led by Trinity College Dublin and the University of Dundee have identified a new genetic mutation linked to the development of a type of eczema known as atopic dermatitis. They found that a mutation in the gene Matt/Tmem79 led to the development of spontaneous dermatitis in mice.
Scientists have puzzled for centuries over how and why multicellular organisms evolved the almost universal trait of using single cells, such as eggs and sperm, to reproduce. Now, researchers have set a big piece of that puzzle into place by applying experimental evolution to transform a single-celled algae into a multicellular one that reproduces by dispersing single cells.
Researchers from North Carolina State Univ., the Univ. of North Carolina at Chapel Hill and Laser Zentrum Hannover have discovered that a naturally occurring compound can be incorporated into 3-D printing processes to create medical implants out of non-toxic polymers. The compound is riboflavin, which is better known as vitamin B2.
In two parallel projects, researchers at the Wyss Institute for Biologically Inspired Engineering have created new genomes inside the bacterium E. coli in ways that could open new possibilities for increasing flexibility, productivity and safety in biotechnology. In the first project, researchers created a novel genome, the first-ever entirely genomically recoded organism. They then greatly expanded genetic changes in the second project.
Human fingertips have several types of sensory neurons that are responsible for relaying touch signals to the central nervous system. Scientists have long believed these neurons followed a linear path to the brain with a "labeled-lines" structure. But new research on mouse whiskers reveals a surprise: At the fine scale, the sensory system's wiring diagram doesn't have a set pattern.
Researchers at Princeton Univ. have found that microRNAs, which are small bits of genetic material capable of repressing the expression of certain genes, may serve as both therapeutic targets and predictors of metastasis, or a cancer’s spread from its initial site to other parts of the body.
Previous studies had established an association between the activity of certain types of neurons and the phase of sleep known as rapid eye movement (REM). Scientists have now found the source of this causal relationship and have used optogenetics techniques to induce and modulate REM sleep in mice.
A team of researchers at Harvard Univ. has found a way to self-assemble complex structures out of gel “bricks” smaller than a grain of salt. The new method could help solve one of the major challenges in tissue engineering: creating injectable components that self-assemble into intricately structured, biocompatible scaffolds at an injury site to help regrow human tissues.
In the parallel universe of the microbiological world, there is a current superstar species of blue-green algae that, through its powers of photosynthesis and carbon dioxide fixation, or uptake, can produce (count ’em) ethanol, hydrogen, butanol, isobutanol and potentially biodiesel. Called Synechocystis 6803, it also has the potential to make commodity chemicals and pharmaceuticals.
By lowering the expression of a single gene, researchers at the National Institutes of Health have extended the average lifespan of a group of mice by about 20%—the equivalent of raising the average human lifespan by 16 years. The research team targeted a gene called mTOR, which is involved in metabolism and energy balance, and may be connected with the increased lifespan associated with caloric restriction.
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of Univ. of California, Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin, the fatty, insulating sheath essential to normal neural conduction.
Researchers in Switzerland have developed a “guide” that can be used to precisely predict the number of proteins a given gene will produce under varying conditions. Each gene has a segment of DNA at its beginning called a promoter, and the researchers generated more than 200 of them, integrated them into a yeast genome, and conducted comparative analysis that generated a model. This work will help biologists to engineer cells.
A team of chemists at Syracuse Univ. has used a temperature-sensitive polymer to regulate DNA interactions in both a DNA-mediated assembly system and a DNA-encoded drug-delivery system. Their findings may improve how nanomaterials self-assemble into functional devices and how anticancer drugs, including doxorubicin, are delivered into the body.
Rice Univ. researchers are making strides toward a set of rules to custom-design Lego-like viral capsid proteins for gene therapy. A recent paper details the team's use of computational and bioengineering methods to combine pieces of very different adeno-associated viruses (AAVs) to create new, benign viruses that can deliver DNA payloads to specific cells.
Researchers at Columbia Univ. Medical Center, working with their collaborators at the Hospital for Special Surgery, have created a fleet of molecular “robots” that can home in on specific human cells and mark them for drug therapy or destruction. The nanorobots—a collection of DNA molecules, some attached to antibodies—were designed to seek a specific set of human blood cells and attach a fluorescent tag to the cell surfaces.
A team of scientists in South Korea have recently developed the most precise method ever used to accomplish a typically messy, clumsy process: inserting DNA into living cells. It combines two high-tech laboratory techniques and allows the researchers to precisely poke holes on the surface of a single cell with a high-powered femtosecond laser and then gently tug a piece of DNA through it using optical tweezers.
Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs, by using molecular “robots” to hone in on more specific populations of cells.
Researchers at the RIKEN-MIT Center for Neural Circuit Genetics and Massachusetts Institute of Technology's Picower Institute for Learning and Memory have used optogenetics techniques to implant false memories into mice, potentially illuminating the mechanisms underlying the human phenomenon of “recalling” experiences that never occurred.
Stem cells are key to the promise of regenerative medicine, but the formula for induced pluripotent stem cells (iPSCs), the cells that can be created from a patient’s own tissues, has limited variations. New research, however, says iPSCs are far more versatile than originally thought. For the first time, researchers have replace a gene once thought impossible to substitute, creating the potential for more flexible recipes.